Eutelmi M 40mg/25mg Tablet ER
By Eutelmi M
Rx
10 Tablet ER in a Strip

Composition
Telmisartan(40mg) + Metoprolol Succinate(23.75mg)

Manufacturer - Europa Healthcare Pvt Ltd
803, Indraprasth Corporate, Opp. Venus Atlantis, Aanandnagar Road, Prahladnagar, Satellite, Ahmedabad-380051

Expires on or after
October, 2025

liver
Eutelmi M 40mg/25mg Tablet ER should be used cautiously in individuals with liver disease. It may be necessary to adjust the dosage of Eutelmi M 40mg/25mg Tablet ER in patients with liver conditions. It is essential to consult your doctor for proper guidance before using this medication.

kidney
Eutelmi M 40mg/25mg Tablet ER is considered safe for use in patients with kidney disease. No dose adjustment is necessary.

alcohol
It is not safe to drink alcohol while taking Eutelmi M 40mg/25mg Tablet ER.

driving
Eutelmi M 40mg/25mg Tablet ER may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Eutelmi M 40mg/25mg Tablet ER should not be used during pregnancy due to the risk to the developing baby. Only in life-threatening situations, a doctor may consider prescribing it if benefits outweigh potential risks. Please consult your doctor before use.

breastfeeding
Eutelmi M 40mg/25mg Tablet ER appears to be safe for use during breastfeeding based on limited human data indicating it poses no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹115
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024